Detalhe da pesquisa
1.
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results.
Clin Cancer Res
; 30(4): 767-778, 2024 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060199
2.
Personalizing first-line treatment in advanced colorectal cancer: Present status and future perspectives.
J Clin Transl Res
; 7(6): 771-785, 2021 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34988329
3.
Immunotherapy in microsatellite instability metastatic colorectal cancer: Current status and future perspectives.
J Clin Transl Res
; 7(4): 511-522, 2021 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34541365
4.
Recent advances and new insights in the management of early-stage epidermal growth factor receptor-mutated non-small-cell lung cancer.
World J Clin Oncol
; 12(10): 912-925, 2021 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34733613
5.
Factores pronósticos de respuesta patológica a la neoadyuvancia estándar en cáncer de recto. Hospital Almenara. 2007-2011 / Prognostic factors of pathological response to the standard neoadjuvant en rectal cancer. Hospital Almenara. 2007-2011
Lima; s.n; 2013. 72 p. tab, graf.
Tese
em Espanhol
| LILACS, LIPECS | ID: lil-724583